82 related articles for article (PubMed ID: 25908332)
1. Evaluating the performance of the focus HerpeSelect® HSV-2 IgG in veterans with chronic hepatitis C infection.
Burton M; Van Wagoner NJ; Sunesara I; Penman A; Swiatlo E; Hook EW
J Med Virol; 2015 Aug; 87(8):1377-81. PubMed ID: 25908332
[TBL] [Abstract][Full Text] [Related]
2. Use of "biokit HSV-2 Rapid Assay" to improve the positive predictive value of Focus HerpeSelect HSV-2 ELISA.
Morrow RA; Friedrich D; Meier A; Corey L
BMC Infect Dis; 2005 Oct; 5():84. PubMed ID: 16225691
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and characteristics of herpes simplex virus type-2 coinfection in veterans with hepatitis C.
Burton MJ; Penman A; Adams-McAlpine G; Overman TL; Hook EW
Am J Med Sci; 2012 Dec; 344(6):436-40. PubMed ID: 22395713
[TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus type 2 antibody detection performance in Kisumu, Kenya, using the Herpeselect ELISA, Kalon ELISA, Western blot and inhibition testing.
Smith JS; Bailey RC; Westreich DJ; Maclean I; Agot K; Ndinya-Achola JO; Hogrefe W; Morrow RA; Moses S
Sex Transm Infect; 2009 Apr; 85(2):92-6. PubMed ID: 18955387
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Serum Samples With Discordant Results in 2 Herpes Simplex Virus Type 2 IgG Assays.
Prince HE; Batterman HJ; Marlowe EM
Sex Transm Dis; 2022 May; 49(5):353-359. PubMed ID: 35067597
[TBL] [Abstract][Full Text] [Related]
6. Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations.
Ashley-Morrow R; Nollkamper J; Robinson NJ; Bishop N; Smith J
Clin Microbiol Infect; 2004 Jun; 10(6):530-6. PubMed ID: 15191381
[TBL] [Abstract][Full Text] [Related]
7. Performance evaluation of four type-specific commercial assays for detection of herpes simplex virus type 1 antibodies in a Middle East and North Africa population.
Aldisi RS; Elsidiq MS; Dargham SR; Sahara AS; Al-Absi ES; Nofal MY; Mohammed LI; Abu-Raddad LJ; Nasrallah GK
J Clin Virol; 2018 Jun; 103():1-7. PubMed ID: 29597097
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity and specificity of herpes simplex virus-2 serological assays among HIV-infected and uninfected urban Ugandans.
Lingappa J; Nakku-Joloba E; Magaret A; Friedrich D; Dragavon J; Kambugu F; Joloba M; Whalen C; Coombs R; Celum C; Morrow RA
Int J STD AIDS; 2010 Sep; 21(9):611-6. PubMed ID: 21097732
[TBL] [Abstract][Full Text] [Related]
9. Comparative performance of a novel herpes simplex virus type 2-specific enzyme-linked immunosorbent assay using a targeted chain oligopeptide, peptide 55.
Al-Sulaiman AM; Vallely PJ; Klapper PE
Clin Vaccine Immunol; 2009 Jun; 16(6):931-4. PubMed ID: 19369475
[TBL] [Abstract][Full Text] [Related]
10. Performance of HSV-2 type specific serological tests in men in Kenya.
Ng'ayo MO; Friedrich D; Holmes KK; Bukusi E; Morrow RA
J Virol Methods; 2010 Feb; 163(2):276-81. PubMed ID: 19854222
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of herpes simplex virus types 1 and 2 among children and adolescents attending a sexual abuse clinic.
Ramos S; Lukefahr JL; Morrow RA; Stanberry LR; Rosenthal SL
Pediatr Infect Dis J; 2006 Oct; 25(10):902-5. PubMed ID: 17006285
[TBL] [Abstract][Full Text] [Related]
12. Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or -2 infection.
Morrow R; Friedrich D
Clin Microbiol Infect; 2006 May; 12(5):463-9. PubMed ID: 16643524
[TBL] [Abstract][Full Text] [Related]
13. Validation of a membrane touch biosensor for the qualitative detection of IgG class antibodies to herpes simplex virus type 2.
Loughman T; Singh B; Seddon B; Noone P; Santhosh P
Analyst; 2017 Jul; 142(15):2725-2734. PubMed ID: 28708188
[TBL] [Abstract][Full Text] [Related]
14. Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in serum and whole blood.
Laderman EI; Whitworth E; Dumaual E; Jones M; Hudak A; Hogrefe W; Carney J; Groen J
Clin Vaccine Immunol; 2008 Jan; 15(1):159-63. PubMed ID: 18003814
[TBL] [Abstract][Full Text] [Related]
15. Novel recombinant ELISA assays for determination of type-specific IgG antibodies against HSV-1 and HSV-2.
Sauerbrei A; Wutzler P
J Virol Methods; 2007 Sep; 144(1-2):138-42. PubMed ID: 17548119
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of commercial herpes simplex virus IgG and IgM enzyme immunoassays.
Liermann K; Schäfler A; Henke A; Sauerbrei A
J Virol Methods; 2014 Apr; 199():29-34. PubMed ID: 24418499
[TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus type 2 (HSV-2) IgG index values in two immunoassays in relation to HSV-2 IgG inhibition assay results.
Prince HE; Batterman HJ; Schwab DA
Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114864. PubMed ID: 31395403
[TBL] [Abstract][Full Text] [Related]
18. Clinical correlates of index values in the focus HerpeSelect ELISA for antibodies to herpes simplex virus type 2 (HSV-2).
Ashley Morrow R; Krantz E; Friedrich D; Wald A
J Clin Virol; 2006 Jun; 36(2):141-5. PubMed ID: 16677855
[TBL] [Abstract][Full Text] [Related]
19. [Serologic examination for childhood herpes simplex virus infection].
Tang JP; Yang YJ; Zhang D; Li LP
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Dec; 8(6):476-8. PubMed ID: 17178039
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence and risk factors for herpes simplex virus infection in a population of HIV-infected patients in Canada.
Romanowski B; Myziuk LN; Walmsley SL; Trottier S; Singh AE; Houston S; Joffe M; Chiu I
Sex Transm Dis; 2009 Mar; 36(3):165-9. PubMed ID: 19098690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
